You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
31 March 2020
Resaphene Suisse AG: Correction of the ad hoc announcement dated March 30, 2020 Resaphene Suisse AG has announced the withdrawal of inclusion in the Vienna MTF at the Vienna Stock Exchange
30 March 2020
Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange
21 January 2020
Resaphene Suisse AG: Charité Ethics Committee in Berlin approves study on tinniwell tinnitus therapy
5 June 2019
Resaphene Suisse AG: US Patent Office Announces Patent for Tinnitus Therapy tinniwell (news with additional features)
7 December 2018
Resaphene Suisse AG: European Patent Office announces patent for tinnitus therapy (news with additional features)
30 September 2018
Resaphene Suisse AG: Annual General Meeting approves capital increase with subscription rights for existing shareholders